Cargando…
Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older
PURPOSE: This retrospective observational study investigated the efficacy and safety of vancomycin to treat patients aged 80 years and older. In particular, the associations between vancomycin trough concentration (VTC) and treatment outcomes or nephrotoxicity were explored. PATIENTS AND METHODS: Pa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179733/ https://www.ncbi.nlm.nih.gov/pubmed/34103905 http://dx.doi.org/10.2147/CIA.S308878 |
_version_ | 1783703849122398208 |
---|---|
author | Wang, Yunchao Dai, Ning Wei, Wei Jiang, Chunyan |
author_facet | Wang, Yunchao Dai, Ning Wei, Wei Jiang, Chunyan |
author_sort | Wang, Yunchao |
collection | PubMed |
description | PURPOSE: This retrospective observational study investigated the efficacy and safety of vancomycin to treat patients aged 80 years and older. In particular, the associations between vancomycin trough concentration (VTC) and treatment outcomes or nephrotoxicity were explored. PATIENTS AND METHODS: Patients aged ≥80 years had received ≥3 vancomycin treatments and ≥1 detection of VTC. Treatment outcomes were defined as success or failure. Nephrotoxicity was considered an increase in serum creatinine ≥ 44.2 mmol/L, or 50% above baseline, for ≥2 consecutive days. Univariate and multivariate analyses were performed to identify risk factors for treatment failure and nephrotoxicity. RESULTS: Of 349 patients, 120 (34.4%) experienced treatment failure. For patients with VTCs at <10, 10–15, 15–20, and ≥20 µg/mL, the clinical response rates were, respectively, 77.8, 77.0, 80.5, and 61.0%; the 30-day mortality rates were 2.8, 15.0, 15.3, and 37.8%; and the rates of persistent bacteremia were 16.7, 12.4, 11.9, and 11.0%. The multivariate analysis indicated that blood urea nitrogen ≥11 g/dL and heart failure were independently associated with treatment failure; but not VTC (P = 0.004, 0.016, 0.828, respectively). During vancomycin treatment, 42 (12.0%) patients experienced nephrotoxicity with recovery time 7.5 ± 4.5 days. Fewer than half of patients with nephrotoxicity recovered after suspending vancomycin application. The variables found independently associated with increased nephrotoxicity were: VTC ≥15 µg/mL; treatment duration ≥15 d; and concomitant aminoglycosides administration (P = 0.024, 0.035, 0.029). CONCLUSION: In patients aged 80 years and older, elevated VTC level was not associated with favorable treatment outcomes. Patients with VTC ≥20 µg/mL appear to suggest a worsened prognosis compared with lower VTCs. The risk of nephrotoxicity increases with elevated VTC, longer treatment time, and concomitant aminoglycoside administration. |
format | Online Article Text |
id | pubmed-8179733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81797332021-06-07 Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older Wang, Yunchao Dai, Ning Wei, Wei Jiang, Chunyan Clin Interv Aging Original Research PURPOSE: This retrospective observational study investigated the efficacy and safety of vancomycin to treat patients aged 80 years and older. In particular, the associations between vancomycin trough concentration (VTC) and treatment outcomes or nephrotoxicity were explored. PATIENTS AND METHODS: Patients aged ≥80 years had received ≥3 vancomycin treatments and ≥1 detection of VTC. Treatment outcomes were defined as success or failure. Nephrotoxicity was considered an increase in serum creatinine ≥ 44.2 mmol/L, or 50% above baseline, for ≥2 consecutive days. Univariate and multivariate analyses were performed to identify risk factors for treatment failure and nephrotoxicity. RESULTS: Of 349 patients, 120 (34.4%) experienced treatment failure. For patients with VTCs at <10, 10–15, 15–20, and ≥20 µg/mL, the clinical response rates were, respectively, 77.8, 77.0, 80.5, and 61.0%; the 30-day mortality rates were 2.8, 15.0, 15.3, and 37.8%; and the rates of persistent bacteremia were 16.7, 12.4, 11.9, and 11.0%. The multivariate analysis indicated that blood urea nitrogen ≥11 g/dL and heart failure were independently associated with treatment failure; but not VTC (P = 0.004, 0.016, 0.828, respectively). During vancomycin treatment, 42 (12.0%) patients experienced nephrotoxicity with recovery time 7.5 ± 4.5 days. Fewer than half of patients with nephrotoxicity recovered after suspending vancomycin application. The variables found independently associated with increased nephrotoxicity were: VTC ≥15 µg/mL; treatment duration ≥15 d; and concomitant aminoglycosides administration (P = 0.024, 0.035, 0.029). CONCLUSION: In patients aged 80 years and older, elevated VTC level was not associated with favorable treatment outcomes. Patients with VTC ≥20 µg/mL appear to suggest a worsened prognosis compared with lower VTCs. The risk of nephrotoxicity increases with elevated VTC, longer treatment time, and concomitant aminoglycoside administration. Dove 2021-06-01 /pmc/articles/PMC8179733/ /pubmed/34103905 http://dx.doi.org/10.2147/CIA.S308878 Text en © 2021 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Yunchao Dai, Ning Wei, Wei Jiang, Chunyan Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title | Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title_full | Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title_fullStr | Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title_full_unstemmed | Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title_short | Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older |
title_sort | outcomes and nephrotoxicity associated with vancomycin treatment in patients 80 years and older |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179733/ https://www.ncbi.nlm.nih.gov/pubmed/34103905 http://dx.doi.org/10.2147/CIA.S308878 |
work_keys_str_mv | AT wangyunchao outcomesandnephrotoxicityassociatedwithvancomycintreatmentinpatients80yearsandolder AT daining outcomesandnephrotoxicityassociatedwithvancomycintreatmentinpatients80yearsandolder AT weiwei outcomesandnephrotoxicityassociatedwithvancomycintreatmentinpatients80yearsandolder AT jiangchunyan outcomesandnephrotoxicityassociatedwithvancomycintreatmentinpatients80yearsandolder |